Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: A double blind, placebo-controlled study
详细信息 查看全文
- 作者：Max E. Butterfielda ; mbutter@pointloma.edu" class="auth_mail" title="E-mail the corresponding author ; Jaime Saalb ; Benjamin Youngb ; Joel L. Youngb ; c ; d
- 关键词：ADHD ; Attention Deficit/Hyperactivity Disorder ; ADHD &ndash ; RS ; Attention Deficit Hyperactivity Disorder Rating Scale ; ASEX ; Arizona Sexual Experience Questionnaire ; CGI&mdash ; I ; Clinical Global Impression Scale&mdash ; Improvement ; CGI&mdash ; S ; Clinical Global Impression Scale&mdash ; Severity ; C-SSRS ; Columbia Suicide Severity Rating Scale ; FSI ; Fatigue Symptom Inventory ; HAM &ndash ; A ; Hamilton Anxiety Inventory ; HAM &ndash ; D ; Hamilton Depression Rating Scale ; RCBM ; Rochester Center for Behavio
- 刊名：Psychiatry Research
- 出版年：2016
- 出版时间：28 February 2016
- 年：2016
- 卷：236
- 期：Complete
- 页码：136-141
- 全文大小：291 K
文摘
- •
Guanfacine hydrochloride was associated with clinical improvement of ADHD.
- •
Placebo was associated with clinical improvement of ADHD.
- •
Guanfacine hydrochloride and placebo had similar efficacy, safety, and tolerability.